Device
Sinopsys Lacrimal Stent
Sinopsys Lacrimal Stent is a medical device with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph early_phase_1
2
50%
Ph not_applicable
2
50%
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Early Phase 1First-in-human
2(50.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Early Phase 1Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Other(1)
Detailed Status
Completed3
Suspended1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Early Phase 1
Trials by Phase
Early Phase 12 (50.0%)
N/A2 (50.0%)
Trials by Status
completed375%
suspended125%
Recent Activity
0 active trials
Showing 4 of 4
suspendednot_applicable
Sinopsys Lacrimal Stent Study for Patients With Chronic Sinusitis or CRS
NCT03066908
completednot_applicable
Sinopsys® Lacrimal Stent Indicated for Sinus Irrigation
NCT03304951
completedearly_phase_1
The Sinopsys Lacrimal Stent for Lacrimal System Repair in Epiphora
NCT02240615
completedearly_phase_1
Sinopsys Lacrimal Stent Indicated for Sinus Irrigation
NCT02297243
Clinical Trials (4)
Showing 4 of 4 trials
NCT03066908Not Applicable
Sinopsys Lacrimal Stent Study for Patients With Chronic Sinusitis or CRS
NCT03304951Not Applicable
Sinopsys® Lacrimal Stent Indicated for Sinus Irrigation
NCT02240615Early Phase 1
The Sinopsys Lacrimal Stent for Lacrimal System Repair in Epiphora
NCT02297243Early Phase 1
Sinopsys Lacrimal Stent Indicated for Sinus Irrigation
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4